Treatment Options and Prognostic Risk Factors for Urachal Carcinoma: A Multicetnter Retrospective Study
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS(2023)
Abstract
Purpose: Urachal carcinoma (UC) is a rare genitourinary cancer with an insidious onset, high risk of recurrence, and a poor prognosis. Surgical resection alone has difficulty in controlling the tumor. We aim to explore treatment options and prognostic risk factors for UC based on a multicenter cohort and long-term follow-up database. Materials and Methods: The clinical data, treatment and follow-up results of 163 patients with UC in 6 medical centers were analyzed retrospectively. Kaplan-Meier analysis and a Cox proportional hazards model were used to assess the treatment options and prognostic risk factors for UC. Results: Kaplan-Meier analysis showed no difference in the 5-year recurrence-free survival rate (P =0.282) or overall survival rate (P =0.673) between extended partial cystectomy (EPC) and radical cystectomy (RC) for patients at stage III and below. Whether bilateral pelvic lymph nodes were dissected was also not significantly correlated with the patient's recurrence (P =0.921) or prognosis (P =0.741). Postoperative adjuvant chemotherapy significantly reduced the recurrence rate of patients with stage IIIb or below (P =0.005). Combined treatment of postoperative recurrence patients prolonged the survival time of patients compared with single chemotherapy or conservative treatment (34.022+5.031 vs. 12.837+2.349 or 6.192+0.875 months, P < 0.001). Kaplan-Meier and univariate Cox regression analyses showed that age > 55 years, Sheldon stage, carbohydrate antigen 19-9 (CA19-9) > 9.935 U/mL, carbohydrate antigen 72-4 (CA724) > 6.02 U/mL, and postoperative adjuvant chemotherapy were closely related to the overall survival and recurrence-free survival of patients (P < 0.05). Multivariate Cox proportional hazard regression confirmed that the Sheldon stage and CA724 > 6.02 U/mL were independent recurrence risk factors. Conclusions: EPC or RC provides similar oncologic results for UC, but bilateral pelvic lymph node dissection is not necessary in early-stage patients. Postoperative adjuvant chemotherapy can significantly reduce the recurrence rate, and combination therapy may provide bet -ter survival outcomes. CA724 can predict tumor recurrence or metastasis at an early stage. (c) 2022 Elsevier Inc. All rights reserved.
MoreTranslated text
Key words
Urachal carcinoma,Treatment options,Partial cystectomy,Adjuvant chemotherapy,CA724,Prognosis
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined